Yu Pengtao sold 5,749 shares of Zepp Health Corp at $4.30 for −$24.7k on Sep 23, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Industrial Designer
Chief Industrial Designer
Filed Sep 25, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$24,723.57Shares × reported price
Shares traded
5,749American depositary shares
Price per share
$4.30Reported price. Read footnotes for ranges.
% of reported position traded
5.3%This security and ownership context
Holdings after
102,742Direct
Trade date
Sep 23, 2026Sell
Filed
Sep 25, 2026, 6:45 AM ET2-day reporting delay
Accession
0001104659-26-110593Code S · Transaction 229534
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 108,491 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 24, 2026Sell4,251$4.09−$17,386.59Trade 229535
2 transaction rows in this filing. Joint filers share the same rows.

ZEPP price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ZEPP · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d −7.5%30d −37%90d180d1y

Footnotes in full

F1: These American depositary shares (ADSs), each representing 16 Class A ordinary shares, were previously acquired upon vesting and settlement of the restricted share units. F2: The ADSs were sold for personal tax arrangements. F3: The price reported represents the weighted average sale price. These ADSs were sold in multiple transactions at prices ranging from $4.30 to $4.32 per ADS. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the range set forth in this footnote.